GALAXYSURF — Galaxy Surfactants Balance Sheet
0.000.00%
- IN₹73.11bn
- IN₹69.24bn
- IN₹42.24bn
- 90
- 28
- 12
- 37
Annual balance sheet for Galaxy Surfactants, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | — | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,539 | 692 | 2,465 | 4,381 | 5,093 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,682 | 7,764 | 6,986 | 6,947 | 8,326 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,577 | 15,702 | 16,019 | 17,020 | 20,936 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8,275 | 9,577 | 10,545 | 11,241 | 12,859 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,495 | 26,006 | 27,345 | 29,147 | 34,621 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,201 | 8,654 | 6,800 | 6,031 | 9,783 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,481 | 10,262 | 8,519 | 7,354 | 10,996 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13,014 | 15,744 | 18,826 | 21,793 | 23,625 |
| Total Liabilities & Shareholders' Equity | 20,495 | 26,006 | 27,345 | 29,147 | 34,621 |
| Total Common Shares Outstanding |